Mdxhealth SA income statement

In fiscal 2025, Mdxhealth SA reported revenue of $108m, up 19.8% on the year before, operating income of −$14.4m (a -13.4% margin) and net income of −$33.5m, or −$0.67 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Mdxhealth SA: income statement, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	12	18	22	37	70	90	108
Cost of revenue	12	10	12	18	26	35	38
Gross profit	0	8	11	19	44	55	70
Research and development	9	5	6	5	6	11	10
General and administrative	—	—	—	4	—	—	—
Operating income	−43	−27	−27	−38	−27	−25	−14
Interest expense	0	0	2	1	0	0	1
Income before tax	−44	−29	−29	−44	−43	−38	−35
Income tax	−1	0	0	0	0	0	−2
Net income	−43	−29	−29	−44	−43	−38	−34
Diluted EPS	−$0.69	$0.34	$2.38	−$2.78	−$1.66	−$1.16	−$0.67
Diluted shares (average)	2m	83m	12m	16m	26m	33m	50m
EBITDA	−42	−26	−26	−35	−23	−20	−9

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BDSX vs MDXH HBIO vs MDXH CDXS vs MDXH

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Mdxhealth SA's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Mdxhealth SA.